Strategies have been developed to regulate TAM functions through nanoparticles, such as reshaping M2 TAMs into M1 anti-tumor macrophages and blocking the CD47-SIRPα pathway to enhance cancer immunotherapy. The gene discussed is CD47; the disease is cancer.